Susan Kay Schultz

powered by
COS Expertise®
University of Iowa
Carver College of Medicine
Psychiatry
Geriatric
ProfessorAppointed: 2007
University of Iowa
Carver College of Medicine
Center on Aging
Clinical Research
Associate DirectorAppointed: 2003
University of Iowa
Carver College of Medicine
Psychiatry
Geriatric Psychiatry
Associate ProfessorAppointed: 2000
Professional Headshot of Susan Kay Schultz

Mailing Address

2-207 Medical Education Building
University of Iowa
Iowa City, Iowa
United States

Contact Information

Phone: (319) 335-6956
Fax: (319) 353-3003
susan-schultz@uiowa.edu

Qualifications

M.D., University of Nebraska Medical Center, Medicine, 1990.
B.A., Nebraska Wesleyan University, Biology and English, 1986.

Expertise and Research Interests

My research interests are in the area of geriatric psychiatry.
My current areas of research interest include:
Aging, dementia, psychosis in late life, antipsychotic-induced movement disorders in the elderly, mild cognitive impairment, functional brain imaging.

My current projects are:
Cerebral blood flow, cognition and psychosis in the elderly.
Psychosis in the context of dementia syndromes, and antipsychotic treatment in this group.
Alzheimer's disease
Risk factors for cognitive decline in later life, e.g., previous exposure to cancer treatments.

Other Expertise

Specialty Certification in Geriatric Psychiatry and Psychosomatic Medicine.

Deputy Editor of the American Journal of Psychiatry

Associate Editor, Geriatric Review Syllabus 6th Edition, 2006.

Future Research

In the future, I hope to conduct research in the areas of neuroimaging in aging and the treatment of psychosis in dementia.

Keywords

COS Keywords:

Gerontology, Psychiatry, Psychosis, Schizophrenia.

Memberships

American Association for Geriatric Psychiatry
American Board of Psychiatry and Neurology
American Geriatrics Society
American Psychiatric Association
Gerontological Society of America
International College of Geriatric Psychoneuropharmacology
Society of Biological Psychiatry

Honors and Awards

2007, Advisory Committee Member, Food and Drug Administration Psychopharmacologic Drug Advisory Committee
2005, Deputy Editor, American Journal of Psychiatry
2005, Study Section Member, National Institutes of Health (NIH)
2004, Interventions Review Committee, Special Emphasis Panel, National Institutes of Health (NIH)
2004-2007, American Association for Geriatric Psychiatry, Board of Directors
2003-2008, Research Committee Chairman, American Association for Geriatric Psychiatry
2002, American Association for Geriatric Psychiatry, Education Committee Chair, AAGP
2001, AAGP Liaison to the American Geriatric Society, AAGP
2000, Klerman Award for Outstanding Clinical Investigators, National Alliance for Research on Schizophrenia and Depression (NARSAD)
2000, Associate Member, American College of Neuropsychopharmacology
1999, Young Investigator Travel Award, American College of Neurospychopharmacology
1999, Research Travel Award, International Congress for Schizophrenia
1998, Mentored Clinical Scientist Career Development Award, National Institute of Mental Health
1996, Young Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD)
1995, Participant, Summer Research Institute in Geriatric Psychiatry, University of California San Diego, National Institute of Mental Health

Previous Positions

1995-2000, Assistant Professor, University of Iowa, Carver College of Medicine, Psychiatry
1993-1995, Postdoctoral Fellow, University of Iowa, Carver College of Medicine, Psychiatry, Schizophrenia Research
1990-1994, Resident Physician, University of Iowa, Hospitals and Clinics, Psychiatry

Funding Received

  • National Institutes of Health (NIH): Cognitive Enhancers Explored with PET Imaging, $551,250, Sep 1, 2001 to Jun 30, 2004.
  • US Department of Health & Human Services, National Institutes of Health: Atypical Antipsychotic Discontinuation in Alzheimer’s Disease, $921,875, Oct 1, 2003 to Sep 30, 2008.
  • Boehringer Ingelheim Pharmaceuticals, Inc.: A Phase II, Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Milticenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer's Type, $118,880, May 27, 2003 to May 27, 2004.
  • Nellie Ball Trust Fund for Schizophrenia Research: Social Adaptive and Cognitive Function Among Older Patients with Schizophrenia, $18,700, Jun 1, 2001 to May 31, 2002.
  • National Alliance for Research on Schizophrenia and Depression: The Relationship between Tardive Dyskinesia, Diabetes Mellitus and Phenylalanine Metabolism, $41,000, Jun 1996 to Jun 1998.
  • Co-Investigator, Reynold Foundation PI: Rosenthal G, Jogerst G: Strengthening Geriatric Training at Iowa, $500,000, Jul 1, 2001 to Jun 30, 2005.
  • NIH Subcontract with University of North Carolina: Clinical Atypical Antipsychotic Trial of Intervention Effectiveness: CATIE, $161,221, Feb 6, 2001 to Sep 30, 2004.
  • National Institute of Mental Health: Career Development Award: Neuroleptics and Aging: Preventing Tardive Dyskinesia, $612,128, Aug 1, 1998 to Jul 31, 2003.
  • National Cancer Institute: Elderly Breast Cancer Survivors: Risk Factors for Neurodegeneration R01, , 2007 to 2012.
  • National Institutes of Health (NIH): University of Iowa Cancer and Aging Program, , 2006 to 2007.

Publications

  • Sattar SP, Schultz SK, Arndt S, Soundy T, Petty F (Nov 2007) Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study., South Dakota medicine : the journal of the South Dakota State Medical Association, 60 (11), 437, 439-41, 443 pas Abstract
  • Schultz SK (Jun 2007) Depression in the older adult: the challenge of medical comorbidity., The American journal of psychiatry, 164 (6), 847-8 Abstract
  • Faison WE, Schultz SK, Aerssens J, Alvidrez J, Anand R, Farrer LA, Jarvik L, Manly J, McRae T, Murphy GM, Olin JT, Regier D, Sano M, Mintzer JE (Jun 2007) Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future., International psychogeriatrics / IPA, 19 (3), 539-58 Abstract
  • O'Leary DS, Block RI, Koeppel JA, Schultz SK, Magnotta VA, Ponto LB, Watkins GL, Hichwa RD (Apr 2007) Effects of smoking marijuana on focal attention and brain blood flow., Human psychopharmacology, 22 (3), 135-48 Abstract
  • Fiedorowicz JG, Moser DJ, Hynes SM, Beglinger LJ, Schultz SK, Ellingrod VL (Feb 2007) LA allelic heterozygosity of the 5HTTLPR polymorphism is associated with higher cognitive function and lower interpersonal sensitivity., Psychiatric genetics, 17 (1), 3-4 Abstract
  • Duff K, Beglinger LJ, Schultz SK, Moser DJ, McCaffrey RJ, Haase RF, Westervelt HJ, Langbehn DR, Paulsen JS (Jan 2007) Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index., Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 22 (1), 15-24 Abstract
  • Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH (Oct 2006) Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects., Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 31 (10), 2281-8 Abstract
  • Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga C, Patterson SL, McIntyre JS, Goldman HH, Yudofsky SC, Hales RE, Rapaport MH, Hales D, Krajeski J, Kupfer DJ, Badaracco MA, Scully JH (Sep 2006) Conflict of interest, round 2., The American journal of psychiatry, 163 (9), 1481-3 Abstract
  • Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Freedman R (Apr 2006) Conflict of interest., The American journal of psychiatry, 163 (4), 571-3 Abstract
  • Turvey CL, Schultz SK, Klein DM (2006) Alcohol use and health outcomes in the oldest old., Substance abuse treatment, prevention, and policy, 1, 8 Abstract
  • Chen X, Magnotta VA, Duff K, Boles Ponto LL, Schultz SK (2006) Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits., The Journal of neuropsychiatry and clinical neurosciences, 18 (2), 178-85 Abstract
  • Alexopoulos GS, Schultz SK, Lebowitz BD (Aug 2005) Late-life depression: a model for medical classification., Biological Psychiatry, 58 (4), 283-9 Abstract
  • Moser DJ, Reese RL, Schultz SK, Benjamin ML, Arndt S, Fleming FW, Andreasen NC (Jun 2005) Informed consent in medication-free schizophrenia research., The American Journal of Psychiatry, 162 (6), 1209-11 Abstract
  • Smith M, Schultz SK (Jan 2005) Managing perplexing patients: the case of Helen., Issues in Mental Health Nursing, 26 (1), 47-63 Abstract
  • Moser DJ, Hoth KF, Robinson RG, Paulsen JS, Sinkey CA, Benjamin ML, Schultz SK, Haynes WG (Nov 2004) Blood vessel function and cognition in elderly patients with atherosclerosis., Stroke; a Journal of Cerebral Circulation, 35 (11), e369-72 Abstract
  • Schultz SK, Hoth A, Buckwalter K, Anxiety and Impaired Social Function in the Elderly, Annals of Clinical Psychiatry, 16, 1-4, 2004
  • Ponto LLB, Schultz SK, Watkins GL, Hichwa RD., Technical issues in the determination of cerebrovascular reserve in elderly subjects using [15O]water PET imaging, Neuroimage, 21(1), 201-10, 2004
  • Boles Ponto LL, Schultz SK, Leonard Watkins G, Hichwa RD (Jan 2004) Technical issues in the determination of cerebrovascular reserve in elderly subjects using 15O-water PET imaging., Neuroimage, 21 (1), 201-10 Abstract
  • Schultz SK, Hoth A, Buckwalter K (Jan-Mar 2004) Anxiety and impaired social function in the elderly., Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists., 16 (1), 47-51 Abstract
  • Schultz SK, Arndt S, Liesveld J, Locations of facilities with special programs for older substance abuse clients in the US, International Journal of Geriatric Psychiatry, 18(9), 839-43, September 2003 Abstract
  • Schultz SK, Arndt S, Liesveld J (Sep 2003) Locations of facilities with special programs for older substance abuse clients in the US., International Journal of Geriatric Psychiatry, 18 (9), 839-43 Abstract
  • Ponto LL, Schultz SK, Ginkgo biloba extract: review of CNS effects, Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists., 15(2), 109-19, June 2003 Abstract
  • Ponto LL, Schultz SK (Jun 2003) Ginkgo biloba extract: review of CNS effects., Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists., 15 (2), 109-19 Abstract
  • Schultz SK, Ellingrod VL, Turvey C, Moser DJ, Arndt S, The influence of cognitive impairment and behavioral dysregulation on daily functioning in the nursing home setting, The American Journal of Psychiatry, 160(3), 582-4, March 2003 Abstract
  • Schultz SK, Ellingrod VL, Turvey C, Moser DJ, Arndt S (Mar 2003) The influence of cognitive impairment and behavioral dysregulation on daily functioning in the nursing home setting., The American Journal of Psychiatry, 160 (3), 582-4 Abstract
  • Schultz SK, Ellingrod VL, Moser DJ, Kutschner E, Turvey C, Arndt S, The influence of cognitive impairment and psychiatric symptoms on daily functioning in nursing facilities: a longitudinal study, Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists., 14(4), 209-13, December 2002 Abstract
  • Schultz SK, Ellingrod VL, Moser DJ, Kutschner E, Turvey C, Arndt S (Dec 2002) The influence of cognitive impairment and psychiatric symptoms on daily functioning in nursing facilities: a longitudinal study., Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists., 14 (4), 209-13 Abstract
  • Schultz SK, O'Leary DS, Boles Ponto LL, Arndt S, Magnotta V, Watkins GL, Hichwa RD, Andreasen NC (Winter 2002) Age and regional cerebral blood flow in schizophrenia: age effects in anterior cingulate, frontal, and parietal cortex., The Journal of Neuropsychiatry and Clinical Neurosciences, 14 (1), 19-24 Abstract
  • Ellingrod VL, Schultz SK, Arndt S, Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6, Pharmacotherapy, 22(11), 1416-9, November 2002 Abstract
  • Kraemer HC, Schultz SK, Arndt S, Biomarkers in psychiatry: methodological issues, The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry., 10(6), 653-9, 2002 Abstract
  • Schultz SK, Arndt S, Lutz GM, Petersen A, Turvey CL, Alcohol use among older persons in a rural state, The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry., 10(6), 750-3, 2002 Abstract
  • Ellingrod VL, Schultz SK, Arndt S (Nov 2002) Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6., Pharmacotherapy, 22 (11), 1416-9 Abstract
  • Moser DJ, Schultz SK, Arndt S, Benjamin ML, Fleming FW, Brems CS, Paulsen JS, Appelbaum PS, Andreasen NC, Capacity to provide informed consent for participation in schizophrenia and HIV research, The American Journal of Psychiatry, 159(7), 1201-7, July 2002 Abstract
  • Moser DJ, Schultz SK, Arndt S, Benjamin ML, Fleming FW, Brems CS, Paulsen JS, Appelbaum PS, Andreasen NC (Jul 2002) Capacity to provide informed consent for participation in schizophrenia and HIV research., The American Journal of Psychiatry, 159 (7), 1201-7 Abstract
  • O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, Ponto LB, Watkins GL, Hurtig RR, Hichwa RD, Effects of smoking marijuana on brain perfusion and cognition, Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology., 26(6), 802-16, June 2002 Abstract
  • Ellingrod VL, Miller D, Schultz SK, Wehring H, Arndt S, CYP2D6 polymorphisms and atypical antipsychotic weight gain, Psychiatric Genetics, 12(1), 55-8, March 2002 Abstract
  • Ellingrod VL, Miller D, Schultz SK, Wehring H, Arndt S (Mar 2002) CYP2D6 polymorphisms and atypical antipsychotic weight gain., Psychiatric Genetics, 12 (1), 55-8 Abstract
  • Arndt S, Schultz SK, Turvey C, Petersen A, Screening for alcoholism in the primary care setting: are we talking to the right people?, Journal of Family Practice, 51(1), 41-6, January 2002 Abstract
  • Ellingrod VL, Schultz SK, Ekstam-Smith K, Kutscher E, Turvey C, Arndt S, Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis, Pharmacotherapy, 22(1), 1-5, January 2002 Abstract
  • Schultz SK, O'Leary DS, Boles Ponto LL, Arndt S, Magnotta V, Watkins GL, Hichwa RD, Andreasen NC, Age and regional cerebral blood flow in schizophrenia: age effects in anterior cingulate, frontal, and parietal cortex, The Journal of Neuropsychiatry and Clinical Neurosciences, 14(1), 19-24, Winter 2002 Abstract
  • Arndt S, Schultz SK, Turvey C, Petersen A (Jan 2002) Screening for alcoholism in the primary care setting: are we talking to the right people?, The Journal of Family Practice, 51 (1), 41-6 Abstract
  • Ellingrod VL, Schultz SK, Ekstam-Smith K, Kutscher E, Turvey C, Arndt S (Jan 2002) Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis., Pharmacotherapy, 22 (1), 1-5 Abstract
  • Kraemer HC, Schultz SK, Arndt S (Nov-Dec 2002) Biomarkers in psychiatry: methodological issues., The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry., 10 (6), 653-9 Abstract
  • Schultz SK, Arndt S, Lutz GM, Petersen A, Turvey CL (Nov-Dec 2002) Alcohol use among older persons in a rural state., The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry., 10 (6), 750-3 Abstract
  • Cem Atbasoglu E, Schultz SK, Andreasen NC, The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia, The Journal of Neuropsychiatry and Clinical Neurosciences, 13(3), 336-41, Summer 2001 Abstract
  • Turvey CL, Schultz SK, Arndt S, Ellingrod V, Wallace R, Herzog R, Caregiver report of hallucinations and paranoid delusions in elders aged 70 or older, International Psychogeriatrics / Ipa, 13(2), 241-9, June 2001 Abstract
  • Moser DJ, Ferneyhough KC, Bauer RM, Arndt S, Schultz SK, Haynes WG, Staples ED, Alexander J, Davies LK, O'Brien DJ, Unilateral vs. bilateral ultrasound in the monitoring of cerebral microemboli, Ultrasound in Medicine and Biology, 27(6), 757-60, June 2001 Abstract
  • Schultz SK, Conclusions: late-life schizophrenia, Harvard Review of Psychiatry, 9(2), 84-7, 2001 Abstract
  • O'Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, Watkins GL, Hurtig RR, Andreasen NC, Hichwa RD, Acute marijuana effects on rCBF and cognition: a PET study, Neuroreport, 11(17), 3835-41, November 2000 Abstract
  • White T, Schultz SK, Naltrexone treatment for a 3-year-old boy with self-injurious behavior, The American Journal of Psychiatry, 157(10), 1574-82, October 2000 Abstract
  • Schultz SK, Ho BC, Andreasen NC, Clinical features characterizing young-onset and intermediate-onset schizophrenia, The Journal of Neuropsychiatry and Clinical Neurosciences, 12(4), 502-5, 2000 Abstract
  • Whelan FJ, Walker MS, Schultz SK, Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury, Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists, 12(3), 131-5, September 2000 Abstract
  • Schultz SK, Dementia in the twenty-first century, The American Journal of Psychiatry, 157(5), 666-8, May 2000 Abstract
  • Ellingrod VL, Schultz SK, Arndt S, Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score, Psychiatric Genetics, 10(1), 9-11, March 2000 Abstract
  • Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE, Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study, The American Journal of Psychiatry, 157(3), 351-9, March 2000 Abstract
  • Schultz SK, Andreasen NC, Integrating Functional and Structural Imaging, The Neuropathology of Schizophrenia, 2000
  • Turvey C, Schultz SK, Arndt S, Wallace RB, Herzog R, Correlates of memory complaint in a national sample of elders, Journal of The American Geriatrics Society, 48(11), 1435-41, 2000
  • Schultz SK, Ellingrod V, Andreasen, The Association between Risk Factors for Tardive Dyskinesia and Plasma Amino Acids Levels and Phenylalanine-Induced Abnormal Movements, Human Psychopharmacology: Clinical and Experimental, 16, 1-6, 2000
  • Schultz SK, O''Leary DS, Boles Ponto LL, Watkins GL, Hichwa RD, Andreasen NC, Age-related changes in regional cerebral blood flow among young to mid-life adults., Neuroreport, 10(12), 2493-6, 20 1999 Abstract
  • Schultz SK, Andreasen NC, Schizophrenia., 353(9162), 1425-30, 24 Apr 1999 Abstract
  • Schultz SK, Arndt S, Ho BC, Oliver SE, Andreasen NC, Impaired glucose tolerance and abnormal movements in patients with schizophrenia., American Journal of Psychiatry, 156(4), 640-2, April 1999 Abstract
  • Crespo-Facorro B, Piven ML, Schultz SK, Psychosis in late life: how does it fit into current diagnostic criteria?, American Journal of Psychiatry, 156(4), 624-9, April 1999 Abstract
  • Magnotta VA, Andreasen NC, Schultz SK, Harris G, Cizadlo T, Heckel D, Nopoulos P, Flaum M, Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging., Cereb Cortex, 9(2), 151-60, March 1999 Abstract
  • Christensen AJ, Dornink R, Ehlers SL, Schultz SK, Social environment and longevity in schizophrenia, Psychosomatic Medicine, 61(2), 141-5, March 1999 Abstract
  • Woodman C, Schultz SK, Faculty Assessment of Residents and the Psychiatry Resident in Training Examination, Academic Psychiatry, 23, 137-141, 1999
  • Schultz SK, O’Leary DS, Andreasen NC, et al, A positron emission tomography study of age-related changes in regional cerebral blood flow among young to mid-life adults, NeuroReport, 9, 151-60, 1999
  • Schultz S K, Castillo C S, Kosier J T, Robinson R G, Generalized anxiety and depression. Assessment over 2 years after stroke., American Journal of Geriatric Psychiatry, 5(3), 229-37, 1 Jul 1997 Abstract
  • Schultz S K, Anderson E A, van de Borne P, Heart rate variability before and after treatment with electroconvulsive therapy., Journal of Affective Disorders, 44(1), 13-20, June 1997 Abstract
  • Schultz S K, Miller D D, Oliver S E, Arndt S, Flaum M, Andreasen N C, The life course of schizophrenia: age and symptom dimensions., Schizophrenia Research, 23(1), 15-23, 17 Jan 1997 Abstract
  • Robinson RG., Schultz SK, Paradiso S., Treatment of Poststroke Depression, Geriatric Psychopharmacology, 1997
  • Andreasen N C, Flaum M, Schultz S, Duzyurek S, Miller D, Diagnosis, methodology and subtypes of schizophrenia., Neuropsychobiology, 35(2), 61-3, 1997 Abstract
  • Flaum M, Schultz S K, When does amphetamine-induced psychosis become schizophrenia? [clinical conference], American Journal of Psychiatry, 153(6), 812-5, June 1996 Abstract
  • Miller DD., Schultz SK., Alexander B., Rational Pharmacological Approaches in the Management of Treatment-Resistant Schizophrenia, Psychiatric Clinics of North America, 3, 89-118, 1996
  • Flaum M., Schultz SK., The core symptoms of schizophrenia, Annals of Medicine, 28, 525-531, 1996
  • Schultz S K, Miller D D, Arndt S, Ziebell S, Gupta S, Andreasen N C, Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation., Biological Psychiatry, 38(11), 713-9, 1 Dec 1995 Abstract
  • Castillo C S, Schultz S K, Robinson R G, Clinical correlates of early-onset and late-onset poststroke generalized anxiety., American Journal of Psychiatry, 152(8), 1174-9, August 1995 Abstract
  • Gupta S, Andreasen N C, Arndt S, Flaum M, Schultz S K, Hubbard W C, Smith M, Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects., American Journal of Psychiatry, 152(2), 191-6, February 1995 Abstract
  • Travella J I, Forrester A W, Schultz S K, Robinson R G, Depression following myocardial infarction: a one year longitudinal study., International Journal of Psychiatry In Medicine, 24(4), 357-69, 1994 Abstract
  • Andreasen N C, Nopoulos P, Schultz S, Miller D, Gupta S, Swayze V, Flaum M, Positive and negative symptoms of schizophrenia: past, present, and future., Acta Psychiatrica scandinavica. Supplementum, 384, 51-9, 1994 Abstract
  • Boles Ponto LL, Magnotta VA, Moser DJ, Duff KM, Schultz SK, Global cerebral blood flow in relation to cognitive performance and reserve in subjects with mild memory deficits., Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 8 (6), 363-72 Abstract
  • Forman-Hoffman VL, Ruffin T, Schultz SK, Basal metabolic rate in anorexia nervosa patients: using appropriate predictive equations during the refeeding process., Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 (2), 123-7 Abstract
  • Schultz SK, Ellingrod VL, Moser DJ, Kutschner E, Turvey C, Arndt S, The influence of cognitive impairment and psychiatric symptoms on daily functioning in nursing facilities: A longitudinal study, Annals of Clinical Psychiatry, in press
  • Kraemer H, Schultz SK, Arndt S, Biomarkers in Psychiatry: Methodological Issues, American Journal of Geriatric Psychiatry, in press
  • Schultz SK, Ellingrod VL, Turvey C, Moser DJ, Arndt S, The influence of cognitive impairment and behavioral dysregulation on daily functioning in the nursing home setting, American Journal of Psychiatry, in press
  • Schultz SK, Arndt S, Lutz G, Turvey C, Alcohol use in a sample of rural elderly aged 65 and older, American Journal of Geriatric Psychiatry, in press

Profile Details

Last Updated: 4/2/2008

COS Expertise ID #327958
Reference this profile directly: http://myprofile.cos.com/schultzs58